2. Signaling Pathways
  3. PI3K/Akt/mTOR
  4. mTOR
  5. mTOR Activator

mTOR Activator

mTOR Isoform Comparison

mTOR Activators (28):

Cat. No. Product Name Effect Purity
  • HY-B0795
    MHY1485
    		Activator 99.86%
    MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes.
  • HY-N0109
    Salidroside
    		Activator 99.90%
    Salidroside (Rhodioloside) is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
  • HY-N0486
    L-Leucine
    		Activator 99.79%
    L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway.
  • HY-Y0252
    L-Proline
    		Activator ≥98.0%
    L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins.
  • HY-U00434
    3BDO
    		Activator 99.93%
    3BDO is a new mTOR activator which can also inhibit autophagy.
  • HY-114384
    NV-5138
    		Activator ≥98.0%
    NV-5138, a leucine analog, is the first selective and orally active brain mTORC1 activator, binding to Sestrin2. NV-5138 is used for antidepressant studies.
  • HY-114384B
    NV-5138 hydrochloride
    		Activator ≥98.0%
    NV-5138 hydrochloride, a leucine analog, is the first selective and orally active brain mTORC1 activator, binding to Sestrin2. NV-5138 hydrochloride is used for antidepressant studies.
  • HY-N0486S1
    L-Leucine-13C
    		Activator 99.4%
    L-Leucine-13C is the 13C-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-N0486S9
    L-Leucine-d3
    		Activator 99.93%
    L-Leucine-d3 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-D0195
    Acesulfame potassium
    		Activator 99.38%
    Acesulfame potassium is a synthetic sweetener. Long-term use of Acesulfame potassium can affect cognitive function, possibly by altering the neurometabolic functions in mice. Acesulfame potassium can suppress autophagic degradation of PD-L1 in RIL-175 and SK-Hep1 cells through the ERK1/2-mTORC1-ULK1 pathway, which may be related to immune evasion in cancer cells. Acesulfame potassium can be used in research on neurological diseases, metabolic disorders, cancer, and immune evasion.
  • HY-N1501
    Beta-asarone
    		Activator 99.87%
    Beta-asarone is an orally active and BBB-penatrable anti-inflammatory agent and neuroprotective agent, which is the major ingredient of Acorus tatarinowii Schott. Beta-asarone can protect nerve cells from apoptosis and autophagy, as well as myocardial protection. Beta-asarone can be used in the study of neurological and cardiovascular diseases.
  • HY-N0486S8
    L-Leucine-13C6,15N
    		Activator 99.90%
    L-Leucine-13C6,15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-N0486S
    L-Leucine-d10
    		Activator ≥98.0%
    L-Leucine-d10 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-N0486S3
    L-Leucine-15N
    		Activator ≥98.0%
    L-Leucine-15N is the 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1][2].
  • HY-124582
    NEO214
    		Activator ≥98.0%
    NEO214 is an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram (HY-16900) and perillyl alcohol (HY-N7000). It has anti-cancer activity and blood-brain barrier (BBB) permeability. Over sex. NEO214 prevents autophagy-lysosome fusion, thereby blocking autophagic flux and triggering glioma cell death. The process involves mTOR activation, andTFEB(Transcription Factor EB) aggregation. NEO214 inhibitionMacroautophagy/autophagy in glioblastoma cells has the potential to overcome chemotherapy resistance in glioblastoma.
  • HY-N0486S2
    L-Leucine-13C6
    		Activator ≥98.0%
    Leucine-13C6 is the 13C-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-N0486S12
    L-Leucine-d2
    		Activator ≥99.0%
    L-Leucine-d2 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-Y0252R
    L-Proline (Standard)
    		Activator
    L-Proline (Standard) is the analytical standard of L-Proline. This product is intended for research and analytical applications. L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins.
  • HY-N0486S11
    L-Leucine-d
    		Activator
    L-Leucine-d is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].
  • HY-N0486S6
    L-Leucine-2-13C,15N
    		Activator
    L-Leucine-2-13C,15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].